LanceAlanSloanMDFACE, FASN, FACP, FEAA

PubMed

• 189 citations
  Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors.
  João Leonardo Silveira Rossi, Sandra Maria Barbalho, Renan Reverete de Araujo, Marcelo Dib Bechara, Kátia Portero Sloan
  Diabetes/metabolism Research and Reviews. 2021-10-15
• 38 citations
  GLP-1a: Going beyond Traditional Use.
  Lucas Fornari Laurindo, Sandra Maria Barbalho, Elen Landgraf Guiguer, Maricelma da Silva Soares de Souza, Gabriela Achete de Souza
  International Journal of Molecular Sciences. 2022-01-10
• 2 citations
  Glycolipid Metabolic Disorders, Metainflammation, Oxidative Stress, and Cardiovascular Diseases: Unraveling Pathways.
  Enzo Pereira de Lima, Renato Cesar Moretti Jr, Karina Torres Pomini, Lucas Fornari Laurindo, Kátia Portero Sloan
  Biology. 2024-07-12

Journal Articles

• Dietary Intake Association with IFG and Responses of a Lifestyle Changing Protocol in a Community- based Adult Cohort  
  Burini RC, Torezan G, Sloan LA, Corrente JE, McLellan KCP, Endocrinol Metab Synd, 1/1/2014
• Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment  
  McGill JB, Sloan L, et al, Diabetes Care, 1/1/2013
• Efficacy and Safety of Sitagliptin in Patients With Type 2 Diabetes and ESRD Receiving Dialysis: A 54-Week Randomized Trial  
  Ferreira JC, Corry D, Morgensen CE, Sloan L, et al, American Journal of Kidney Diseases, 1/1/2013
• American Association Of Clinical Endocrinologists Medical Guidelines For Clinical Practice For The Diagnosis And Treatment Of Hypertension  
  Sloan, L., Endocrine Practice, 1/1/2006
• ACE Position Statement on the Insulin Resistance Syndrome  
  Sloan, L., Endocr Pract, 1/1/2003
• Join now to see all

Books/Book Chapters

• Dietary Fiber: Production Challenges, Food Sources and Health Benefits 
  Chapter: Evolutionary roles of dietary fiber in succeeding metabolic syndrome (MetS) and its responses to a lifestyle modification program: A Brazilian Community-based study. 
  Mclellan, KCP, Ramos FMM, Corrente JE, Sloan LA, Burini RCNova Publishers, NY2015
• Type 2 Diabetes 
  Chapter: Epigenetics of Glucose Metabolism and the Basis for T2DM Interventions. 
  Page 51 - 70McLellan KCP, Manda RM, Sloan LA, and Burini RCEditors: Masuo K.IntechEdition 1st,2013

Abstracts/Posters

• Tranlation and Cross-cultural adaptation of The Finnish Diabetes Risk Score into Brazilian Portuguese language.
  Sloan KP, Barin EM, Ribeiro RS, de Carvalho JAM, Lindstrom J, Tuomilehto J, Corrente JE, Sloan L, Murta-Nascimento C, WCIRDC Abstracts, Endocr Pract, 16th Annual World Congress on Insulin Resistance Diabetes & Cardiovascular Disease, Los Angeles, CA, 2018, 1/1/2019
• Dairy Consumption is associated with plasma triglycerides reduction and changes in body composition in overweight and obesity: a 12-week intervention study.
  Diegoli ACM, Mclellan KCP, Sloan LA, World Congress on Nutrition and Obesity Prevention Source, Barcelona, Spain, 1/16/2017
• Metabolic and Dietary Factors Associated with Abnormal Glucose Metabolism in Brazilian Adults: A Community-based Study.
  Mclellan, KCP, Kano, H, Manda, R, Corrente JE, Sloan L, Burini RC, Diabetes, 76th Scientific Sessions American Diabetes Association, New Orleans, LA, 1/1/2016
• Nutritional Associations with Sarcopenia in an Elderly Brazilian Community Study.
  Martins LCA, Sloan LA, Mclellan KCP, 8th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Paris, France, 1/4/2015
• Dietary Intake, Physical Activity Level, And Socioeconomic Status As Determinants Of Visceral Obesity In Adults - A Brazilian Community-Based Study.
  Mclellan, KCP, Castanho G, Oliveira, E, Calini, C, Michelin E, Sloan L, Burini R, American Association of Clinical Endocrinologists, Nashville, TN, 1/1/2015
• Safety and Efficacy of Linagliptin in Type 2 Diabetes Patients with Severe Renal Impairment.
  Sloan L, et al, Abstracts of The American Diabetes Association, 1/1/2011
• "Effects of Calcitonin Gene-Related Peptide on in vivo Insulin Action"
  Choi, S.B., Fontoni, S., Sloan, L., Katz, M., and Rossetti, L., Abstracts of European Association for the Study of Diabetes, 1/1/1990
• Join now to see all

Lectures

• "Management of T2DM patients with Diabetic Kidney Disease: Effects of SGLT2 inhibitors and GLP-1 Receptor Agonist on Disease Progression." 
  Las Vegas, NV - 1/4/2018
• "Mechanisms of Diabetic Cardiorenal Disease" 
  Boston, MA - 1/1/2018
• "The choice of Treatments for Type 2 Diabetes Patients with Renal Insufficiency" 
  Buenos Aires, Argentina - 1/25/2017
• "The kidney and glucose-lowering medications for T2D" 
  Ixtapa, Mexico - 1/28/2016
• SGLT2i and DKA Development: Epidemiology, Pathogenesis, and Prevention. 
  Orlando, FL - 1/25/2016
• "SGLT2 inhibitors and diabetic ketoacidosis (DKA) development: Epidemiology, Pathogenesis and Prevention of DKA in Diabetes." 
  Sao Paulo, Brazil - 1/11/2016
• SGLT2 inhibitors and diabetic ketoacidosis (DKA) development: Epidemiology, Pathogenesis and Prevention of DKA in Diabetes. 
  Sao Paulo, Brazil - 1/4/2016
• "New Concepts in the Prevention and Treatment of Diabetic Kidney Disease" 
  Houston Methodist Research Institute, Houston, TX - 1/2/2016
• Type 2 Diabetes Patient Profile: DKA after SGLT2 Inhibitors & ways to prevent DKA. 
  Dallas, TX - 1/24/2015
• "Bariatric Surgery for Diabetes" 
  1/1/2011
• "Thyroid Disease Case studies" 
  1/1/2011
• "An Update in Managing Diabetes" 
  1/1/2010
• "Case Study in CKD Metabolic Bone Management" 
  1/1/2010
• "Vitamin D Deficiency and Diabetes" 
  1/1/2009
• "Practicle Tips for Diabetes Control" 
  1/1/2009
• "Vitamin D and Early CKD Intervention" 
  1/1/2009
• "Current AACE/ADA/TDC Guidelines on The Pharmaceutical Management of Diabetes" 
  1/1/2009
• "Nephrology Perspective on SGLT2 Inhibitors" 
  1/1/2009
• "Vitamin D and the Diabetic Patient" 
  1/1/2008
• "The Use of Pramlitide to Improve Postprandial Glucose Control" 
  1/1/2008
• "Vitamin D Deficiency It's Diagnosis and Management" 
  1/1/2008
• "Endocrine and Metabolic Changes Secondary to CKD and Their Management" 
  1/1/2008
• "Children's Lifestyle Intervention Study (CLIP Study)" 
  1/1/2008
• "Understanding New Treatment Options for Patients with Secondary Hyperparathyroidism Due to CKD Stages 3 and 4" 
  Little Rock, AR - 1/1/2008
• "Management of Non-glycemic Risk Factors for Cardiovascular Disease in Diabetics" 
  1/1/2007
• Join now to see all

Other

• Nephropathy for the Endocrinologist 2004 
  Sloan, L., Texas AACE Syllabus
  1/1/2004
• Nephropathy For The Endocrinologist 
  Sloan, L., AACE/ACE Syllabus
  1/1/2001
• "Texas Diabetes Council Guidelines for Diabetes Care" 
  Sloan, L., et al
  1/1/2000
• Development and Comparison of a Pulsatile Flow Extracorporeal Perfusion Device to a Roller Pump. 
  Sloan, L., Masters Thesis, University of Texas at Austin
  1/1/1983
• "In Vitro Evaluation of Steady Flow versus Pulsatile Flow Cardiopulmonary Bypass Pumps" 
  Sloan, L., Annals of the Texas Medical Association Meeting
  1/1/1981
• "Volume Flow Rate, Velocity Distribution, and Wave Form in Pulsatile Flow Cardiopulmonary Bypass" 
  Sloan, L., Annals of the Texas Medical Association Meeting
  1/1/1980
• Join now to see all